AKT1 and breast carcinoma: The PI3K/AKT/mTOR signaling pathway, critically involved in tumor growth, proliferation, metabolism, and migration, represents one of the most frequently dysregulated pathways in breast cancer therapeutics (Liu et al., 2024).